(Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, November 4 to ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2026 on ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced ...

HLP003 has been granted Breakthrough Therapy Designation by the FDA, which makes HLP003 eligible for an expedited review ...

Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S ...

Revenue of $716.0 million in the third quarter of 2026 increased 8.5% from revenue of $659.9 million for the comparable prior ...

Jefferies, Leerink Partners and TD Cowen are acting as joint book-running managers.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 4, ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial ...

Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and ...

The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the ...

Securing financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering ...